내용 바로 가기

종양학과

정상혈량빈혈(Normovolemic Anemia) 허용

Compliance rates and outcomes associated with a restrictive transfusion policy in gynecologic oncology patients. (새로운 창 열기)

Boone JD, Kim KH, Marques M, Straughn JM.

Source‎: Gynecol Oncol 2014;132(1):227-30.

Indexed‎: PubMed 24512847

DOI‎: 10.1016/j.ygyno.2013.10.019

https://www.ncbi.nlm.nih.gov/pubmed/24512847 (새로운 창 열기)

Liberal or restrictive transfusion in high-risk patients after hip surgery. (새로운 창 열기)

Carson JL, Terrin ML, Noveck H, Sanders DW, Chaitman BR, Rhoads GG, Nemo G, Dragert K, Beaupre L, Hildebrand K, Macaulay W, Lewis C, Cook DR, Dobbin G, Zakriya KJ, Apple FS, Horney RA, Magaziner J; FOCUS Investigators.

Source‎: N Engl J Med 2011;365(26):2453-62.

Indexed‎: PubMed 22168590

DOI‎: 10.1056/NEJMoa1012452

https://www.ncbi.nlm.nih.gov/pubmed/22168590 (새로운 창 열기)

Long-lasting extreme anemia during the therapy of acute lymphoblastic leukemia in a Jehovah's Witness patient. (새로운 창 열기)

Chojnowski K, Janus A, Bliźniewska K, Robak M, Treliński J.

Source‎: Transfusion 2016;56(10):2438-42.

Indexed‎: PubMed 27385671

DOI‎: 10.1111/trf.13703

https://www.ncbi.nlm.nih.gov/pubmed/27385671 (새로운 창 열기)

A multicenter, randomized, controlled clinical trial of transfusion requirements in critical care. (새로운 창 열기)

Hébert PC, Wells G, Blajchman MA, Marshall J, Martin C, Pagliarello G, Tweeddale M, Schweitzer I, Yetisir E; Transfusion Requirements in Critical Care Investigators, Canadian Critical Care Trials Group.

Source‎: N Engl J Med 1999;340(6):409-17.

Indexed‎: PubMed 9971864

DOI‎: 10.1056/NEJM199902113400601

https://www.ncbi.nlm.nih.gov/pubmed/9971864 (새로운 창 열기)

Red blood cell transfusion in non-bleeding critically ill patients with moderate anemia: is there a benefit? (새로운 창 열기)

Leal-Noval SR, Muñoz-Gómez M, Jiménez-Sánchez M, Cayuela A, Leal-Romero M, Puppo-Moreno A, Enamorado J, Arellano-Orden V.

Source‎: Intensive Care Med 2013;39(3):445-53.

Indexed‎: PubMed 23184038

DOI‎: 10.1007/s00134-012-2757-z

https://www.ncbi.nlm.nih.gov/pubmed/23184038 (새로운 창 열기)

How low should we go: A systematic review and meta-analysis of the impact of restrictive red blood cell transfusion strategies in oncology. (새로운 창 열기)

Prescott LS, Taylor JS, Lopez-Olivo MA, Munsell MF, VonVille HM, Lairson DR, Bodurka DC.

Source‎: Cancer Treat Rev 2016;46:1-8.

Indexed‎: PubMed 27046422

DOI‎: 10.1016/j.ctrv.2016.03.010

https://www.ncbi.nlm.nih.gov/pubmed/27046422 (새로운 창 열기)

Trends in red blood cell transfusion and 30-day mortality among hospitalized patients. (새로운 창 열기)

Roubinian NH, Escobar GJ, Liu V, Swain BE, Gardner MN, Kipnis P, Triulzi DJ, Gottschall JL, Wu Y, Carson JL, Kleinman SH, Murphy EL; NHLBI Recipient Epidemiology and Donor Evaluation Study (REDS-III).

Source‎: Transfusion 2014;54(10 Pt 2):2678-86.

Indexed‎: PubMed 25135770

DOI‎: 10.1111/trf.12825

https://www.ncbi.nlm.nih.gov/pubmed/25135770 (새로운 창 열기)

Liberal versus restrictive red blood cell transfusion thresholds in hematopoietic cell transplantation: a randomized, open label, phase III, noninferiority trial. (새로운 창 열기)

Tay J, Allan DS, Chatelain E, Coyle D, Elemary M, Fulford A, Petrcich W, Ramsay T, Walker I, Xenocostas A, Tinmouth A, Fergusson D

Source‎: J Clin Oncol 2020;38(13):1463-73.

Indexed‎: PubMed 32083994

DOI‎: 10.1200/JCO.19.01836

https://www.ncbi.nlm.nih.gov/pubmed/32083994 (새로운 창 열기)

Transfusion indications for patients with cancer. (새로운 창 열기)

Watkins T, Surowiecka MK, McCullough J.

Source‎: Cancer Control 2015;22(1):38-46.

Indexed‎: PubMed 25504277

https://www.ncbi.nlm.nih.gov/pubmed/25504277 (새로운 창 열기)

Restrictive blood transfusion protocol in malignant upper gastrointestinal and pancreatic resections patients reduces blood transfusions with no increase in patient morbidity. (새로운 창 열기)

Wehry J, Agle S, Philips P, Cannon R, Scoggins CR, Puffer L, McMasters KM, Martin RC.

Source‎: Am J Surg 2015;210(6):1197-204.

Indexed‎: PubMed 26602534

DOI‎: 10.1016/j.amjsurg.2015.08.013

https://www.ncbi.nlm.nih.gov/pubmed/26602534 (새로운 창 열기)